semaglutide novo nordisk patent expires next year: faces tough competition in the Chinese obesity market India could soon get a

In 2014, the European Medicines Agency (EMA) approved afamelanotide (Scenesse) for the treatment of EPP, making it the first melanocortin receptor agonist to receive regulatory approval for a medical condition

A., Hooper, L

doi: 10.3389/fendo.2017.00063

These AG 538 bioisosteres possessed similar but weaker biological properties to AG 538 but are more stable and blocked the formation of colonies of prostate and breast cancer cells in soft agar systems (Blum et al, 2003)

This study looked what happened when you stop taking tirzepatide (Mounjaro) after losing weight with it

Toxicol Sci 104, 261273, doi: 10.1093/toxsci/kfn093 (2008)